...
首页> 外文期刊>Chemical research in toxicology >Formation of Benzylic-DNA Adducts Resulting from 7,12-Dimethylbenz(a)anthracene in Vivo.
【24h】

Formation of Benzylic-DNA Adducts Resulting from 7,12-Dimethylbenz(a)anthracene in Vivo.

机译:体内由7,12-二甲基苯并(a)蒽形成的Benzylic-DNA加合物的形成。

获取原文
获取原文并翻译 | 示例
           

摘要

Studies were undertaken to determine the formation of benzylic-DNA adducts in rats administered 7,12-dimethylbenz[a]anthracene (DMBA) and its meso-region metabolites by subcutaneous injection. Here, we show that 7-hydroxymethyl-12-methylbenz[a]anthracene (7-HMBA) and 7-sulfoxymethyl-12-methylbenz[a]anthracene (7-SMBA) gave rise to some benzylic-DNA adducts indistinguishable from adducts formed from DMBA. Adducts were analyzed by butanol enrichment-mediated (32)P-postlabeling assay. Female Sprague-Dawley rats given a combined dose of 420 mumol DMBA/kg b. wt resulted in two major and up to nine minor adducts in the subcutaneous tissue, with chromatographic resemblance to benzylic-DNA adducts prepared in vitro. Subcutaneous administration of 7-HMBA, 7-SMBA, and 7-methyl-12-hydroxymethylbenz[a]anthracene (12-HMBA) (210, 42, and 210 mumol/kg b. wt, respectively) each resulted in one major and several minor benzylic-DNA adducts. From cochromatography with reference adducts, it was concluded that the benzylicDNA adduct 4, derived from the parent compound, comigrates with the major adduct from 7-HMBA and 7-SMBA, whereas adducts 2 and 3 comigrate with adducts resulting from 12-HMBA and 7-methyl-12-sulfooxymethylbenz[a]anthracene, respectively. These data suggest that 7-sulfooxymethyl- and 12-sulfooxymethy derivatives produce distinct adducts. Several major and minor diol epoxide-related DNA adducts were also detected. The diol epoxide- and benzylic-DNA adducts were found in a 2:1 ratio. The oral, intraperitoneal, and intramammiliary treatments with DMBA showed no detectable benzylic adducts in the liver and mammary glands 24 h after the last treatment, although the adduct formation was clearly evident with SMBA and/or HMBA treatments, suggesting that hydroxylation of DMBA to form HMBA may be the rate-limiting step for the meso-methyl substitution pathway. The present study clearly demonstrates the in vivo formation of benzylic-DNA adducts from DMBA. The data also reveal the involvement of the 12-methyl group of DMBA in adduct formation.
机译:进行了研究以确定通过皮下注射给药7,12-二甲基苯并[a]蒽(DMBA)及其介观区代谢产物的大鼠中苄基DNA加合物的形成。在这里,我们表明7-羟甲基-12-甲基苯并[a]蒽(7-HMBA)和7-磺氧基甲基-12-甲基苯并[a]蒽(7-SMBA)产生了一些苄基-DNA加合物,与形成的加合物没有区别来自DMBA。通过丁醇富集介导的(32)P后标记测定法分析加合物。雌性Sprague-Dawley大鼠的合并剂量为420μmolDMBA / kg b。 wt在皮下组织中产生两个主要的加合物,最多可形成九个次要的加合物,其色谱类似于体外制备的苄基DNA加合物。皮下施用7-HMBA,7-SMBA和7-甲基-12-羟甲基苯并[a]蒽(12-HMBA)(分别为210、42和210 mumol / kg体重)分别导致几个次要的苄基DNA加合物。从共色谱法与参考加合物得出的结论是,衍生自母体化合物的苄基DNA加合物4与7-HMBA和7-SMBA的主要加合物相伴,而加合物2和3与由12-HMBA和7生成的加合物相伴。 -甲基-12-磺氧基甲基苯并[a]蒽。这些数据表明7-磺氧基甲基和12-磺氧基甲基衍生物产生不同的加合物。还检测到几种主要和次要的二醇环氧相关的DNA加合物。发现二醇环氧化合物和苄基DNA的加合物的比例为2:1。在最后一次治疗后24小时,DMBA的口服,腹膜内和乳内治疗均未在肝脏和乳腺中检测到苄基加合物,尽管在SMBA和/或HMBA处理中加合物的形成很明显,这表明DMBA的羟基形成HMBA可能是介观甲基取代途径的限速步骤。本研究清楚地证明了DMBA在体内形成苄基DNA加合物。数据还揭示了DMBA的12-甲基与加合物形成有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号